(S)-5-methoxy-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, 98%, 250mg

N-(9-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 98%, 100mg

Long working distance plan 40x/0.65 IOS objective, corrected for 1 mm thickness. WA 2.74mm

[2'-(Di-tert-butyl-phosphanyl)-biphenyl-2-yl]-dimethyl-amine, 98.0%, 25g

3-(5-Mercapto-1,3,4-oxadiazol-2-yl)benzonitrile, 95.0%, 250mg

N-Boc-N-bis(PEG2-acid), 100mg

4''-(Pentyloxy)-[1,1':4',1''-terphenyl]-4-carboxylic acid, 95.0%, 10g

Ethyl 4-amino-2-fluorobenzoate, 95.0%, 25g

2-Methoxy-4-vinylphenol, 95.0%, 1g

7-Aminoheptanoic acid, 97.0%, 5g

4,4'-Di-n-nonyl-2,2'-bipyridine, 96%, 5g

Ethyl 5-nitrobenzo[b]furan-2-carboxylate, 95.0%, 10g

Boc-Val-Pro, 95.0%, 5g